Product Launch Announcement: Geftifine 250 (Gefitinib 250mg) Tablet
We are proud to introduce Geftifine 250 contains Gefitinib 250 mg, an oral targeted anticancer therapy belonging to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) class. It is indicated for the treatment of specific types of non-small cell lung cancer (NSCLC) with susceptible EGFR mutations, as determined by an appropriate diagnostic test. Geftifine 250 is manufactured to high pharmaceutical quality standards to provide consistent efficacy, safety, and reliability.
🔍 Product Overview
Generic Name: Gefitinib
Strength: 250mg
Formulation: Tablets
Primary Indications:
Geftifine 250 (Gefitinib 250mg) Tablet is indicated for the treatment of:
First-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring susceptible EGFR mutations.
Treatment should be initiated based on confirmed EGFR mutation status and under the supervision of an oncologist.
Mechanism of Action:
Gefitinib is a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. It blocks EGFR-mediated signaling pathways involved in tumor cell growth, proliferation, and survival, helping to slow disease progression in patients with EGFR mutation-positive NSCLC.
💡 Key Benefits
- Targeted therapy for EGFR mutation-positive NSCLC.
- Selectively inhibits EGFR signaling to suppress tumor growth.
- Convenient once-daily oral tablet.
- Clinically proven efficacy in appropriately selected patients.
- Manufactured under stringent quality standards for consistent performance and reliability.
🎯 Target Audience
- Medical Oncologists
- Pulmonologists
- Thoracic Oncologists
- Cancer Care Specialists
- Hospitals and Oncology Centers
- Specialty Pharmacies
🏥 Commitment to Clinical Excellence
Geftifine 250 is developed with a commitment to advancing precision oncology through high-quality targeted therapies. Manufactured in compliance with Good Manufacturing Practices (GMP), every batch undergoes rigorous quality control to ensure safety, consistency, and reliability. Our mission is to support healthcare professionals with trusted oncology solutions that enhance patient care.
📦 Availability
Geftifine 250 (Gefitinib 250mg) Tablets are available through authorized distributors and healthcare supply channels. For supply inquiries, bulk orders, or regulatory documentation, please contact our sales or distribution team.
Geftifine 250 – The Power of Targeted Treatment for Lung Cancer.
